РусскийEnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Ambrosova T.N.

    TUMOR NECROSIS FACTOR-α IN COMORBIDITY OF ARTERIAL HYPERTENSION AND OBESITY


    About the author: Ambrosova T.N.
    Heading LITERATURE REVIEWS
    Type of article Review article
    Annotation TNF -α – proinflamatory cytokine which elevated in plasma in obesity, is associated with the development of hyperglycemia and insulin resistance. TNF -α is considered as a mediator of insulin resistance, due to the fact that the expression of TNF -α is expressed in adipocytes visceral adipose tissue, but also in fat cells in obese influenced by lipoprotein released excessive amounts of fatty acids, which reduce the sensitivity of the liver and other tissues to insulin due to irregularities in the postreceptor insulin signal transmission. Visceral adipose tissue is the primary source of free fatty acids. By increasing the free fatty acids in the portal circulation and in conditions of hyperactivation of TNF -α disrupted insulin receptors, which leads to increased lipogenesis and insulin resistance. Research has indicated that excessive TNF-α is synthesized in adipose tissue. Association hypertension and obesity plays a significant role in the development of insulin resistance. The increased expression of TNF -α contributes to the progression of dysmetabolic disorders in .comorbidity of hypertension and obesity.
    Tags tumor necrosis factor – α, arterial hypertension, obesity
    Bibliography
    • Ащеулова Т. В. Фактор некрозу пухлин-α та маса міокарда лівого шлуночка у хворих на артеріальну гіпертензію / Т. В. Ащеулова // Медицина сьогодні і завтра. – 2001. – № 1. – С. 29–31.
    • Ковалева О. Н. Цитокины и ремоделирование миокарда левого желудочка при артериальной гипертензии / О. Н. Ковалева, Т. В. Ащеулова / Кардиология, основанная на доказательства: тезисы докл. Рос. нац. конгр. кардиол. – 2000. – С. 139.
    • Allison D. B. Genetic, environmental, and phenotypic links between body mass index and blood pressure among women / D. B. Allison, S. Heshka, M. C. Neale [et al.] // Am. J. Med. Genet.– 1995. – Vol. 55. – P. 335–341.
    • Asheulova T. Influence of tumor necrosis factor-α activity on left ventricular systolic function in hypertension / T. Asheulova, O. Kovalyova // 3rd International Congress on Coronary Artery Disease "From prevention to intervention". – 2000. – 76 р.
    • Asheulova T. Tumor necrosis factor-α in hypertensive patients: relation to the left ventricular mass / T. Asheulova, О. Kovalyova // European Heart Journal: XXII Congress of the European Society of Cardiology. – 2000. – 99 р.
    • Bazzoni F. The tumor necrosis factor ligand and receptor families / F. Bazzoni, B. Beutler // N. Engl. J. Med. – 1996. – Vol. 334. – P. 1717–1725.
    • Das U. N. Is metabolic syndrome X an inflammatory condition? / U. N. Das // Exp. Biol. Med. – 2002. – Vol. 227. – P. 987–997.
    • Dzienis-Straczkowska S. Soluble tumor necrosis factors in young obese subjects with normal and impaired glucose tolerance / S. Dzienis-Straczkowska, M. Straczkowsi, Z. Stepien [et al.] // Diabetes. – 2003. – Vol. – 26. – P. 875–880.
    • Fernander-Real J. M. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance / J. M. Fernander-Real, M. Broch, W. Ricart [et al.] // Diabetes. – 1998. – Vol. 47. – P. 1757–1762.
    • Festa A. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) / A. Festa, R. Jr.  D'Agostino, G. Howard [et al.] // Circulation. – 2000. – Vol. 102. – P. 42–47.
    • Greenberg A. S. Identifying link between obesity, insulin resistance and β-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes / A.S. Greenberg, M.L. McDaniel // Europ. J. Clin. Invest. – 2002. – Vol. 32, Suppl. 3. – P. 24–34.
    • Heller R. A. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of shed form of the receptor / R. A. Heller, K. Song, M. A. Onasch [et al.] // Proc. Natl. Acad. Sci. USA. – 1990. – Vol. 87. – P. 6151–6155.
    • Hotamisligil G. S. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance / G. S. Hotamisligil, N. S. Shargill, B.M. Spiegeleman // Science. – 1993. – Vol. 5091. – P. 87–91.
    • Hotamisligil G. S. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance / G. S. Hotamisligil, P. Arner [et al.] // J. Clin. Invest. – 1995. – Vol. 95. – P. 2409–2415.
    • Hauner H. Plasma concentration of soluble TNF-α receptors in obese subjects / H. Нauner, А. Mehder, B. Haastert [et al.] // Int. J. Obes. – 1998. – Vol. 22. – P. 1239–1243.
    • Kern P. A. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase / P. A. Kern, M. Saghizadeh [et al.] // J. Clin. Invest. – 1995. – Vol. 95. – P. 2111–2119.
    • Kovalyova O. Left ventricular remodeling and tumor necrosis factor-alpha on hypertension / O. Kovalyova, O. Nyzhegorodtseva // Eur. J. Echocardiography. – 2002. – Vol. 3 (Suppl. 1). – P. 15.
    • Kovalyova O. Tumor necrosis factor-alpha activity in hyper­tensive patients / O. Kovalyova, T. Asheulova // Archives des maladies du Coecur et des Vaisseaux. – 2002. – T. 95, № special III. – P. 78.
    • Loetscher H. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor / H. Loetscher, V. C. E. Pan, H. W. Lahm [et al.] // Cell. – 1990. – Vol. 61. – P. 351–359.
    • Mohamed A. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vitro / A. Mohamed, S. Goodrick, K. Bulmer [et al.] // Am. J. Physiol. Endocrinol. Metab. – 1999. – Vol. 82. – P. 971–975.
    • Nicoletti G. Effect of multidisciplinary program of weight reduction on endothelial functions in obese women / G. Nicoletti, G. Giug­liano, A. Pontillo [et al.] // J. Endocrinol. Invest. – 2003. – Vol. 26. – P. 5–8.
    • Olszanecka-Glinianowicz M. Serum concentration of nitric oxide, tumor necrosis factor-α (TNF-α) and TNF soluble receptors in women with overweight and obesity / M. Olszanecka-Glinianowicz, M. Ginianowicz, B. Zahorska-Markiewicz [et al.] // Metabolism. – 2004. – Vol. 53. – № 10. – Р. 1268–1273.
    • Pausova Z. Gene-environment interactions in hypertension / Z. Pausova, J. Tremblay, P. Hawet // Curr. Hypertens. Rep. – 1999. – № 1. – P. 42–50.
    • Pausova Z. Role of tumor necrosis factor-α gene locus in obesity and obesity-associated hypertension in French Canadians / Z. Pausova, B. Deslaurilrs, D. Gandet [et al.] // Hypertension. – 2000. – Vol. 36. – P. 14–19.
    • Paquot N. No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: fe fusion protein in obese insulin-resistant patients / N. Paquot, M. J. Castillo [et al.] // J. Clin. Endocrinol. Metab. – 2000. – Vol. 85. – P. 1316–1319.
    • Spiegeleman B. M. Through thick and thin: wasting, obesity and TNF-alpha / B. M. Spiegeleman, G. S. Hotamisligil // Cell. – 1993. – Vol. 73. – P. 625–627.
    • Saghizadeh M. The expression of TNF-α by human muscle: relationship to insulin resistance / M. Saghizadeh, J. M. Ong, W. T. Barvey [et al.] // J. Clin. Invest. – 1996. – Vol. 97. – P. 1111–1116.
    • Salmenniemi U. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin cytokines and adhesion molecules in subjects with metabolic syndrome / U. Salmenniemi, E. Ruotsalainen, J. Pihlajamäki [et al.] // Circulation. – 2000. – Vol. 110. – P. 3842–3848.
    • Tartaglia L. A. A novel domain within the 55 kd TNF receptor signals cell death / L. A. Tartaglia, T. M. Ayres, G. H. W. Wong [et al.] // Cell. – 1993. – Vol. 74. – P.845–853.
    • Walach D. Tumor necrosis factor receptor and Fas signaling mechanisms / D. Walach, E. E. Varfolomeev, M. L. Malinin [et al.] // Annu. Rev. Immunol. – 1999. – Vol. 17. – P. 331–367.
    • Winkler G. Expression of tumor necrosis factor-α (TNF-α) protein in the subcutaneous and visceral adipose tissue in correlation with adypocyte cell volume, serum TNF-α, soluble serum TNF-receptor-2 concentration and C-peptide level / G. Winkler, S. Kiss, L. Keszthelyi [et al.] // Pour. J. Endocrin. – 2003. – Vol. 143. – P. 129–135.
    • Xu H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance / H. Xu, G. T. Barner, Q. Vang [et al.] // J. Clin. Invest. – 2003. – Vol. 112. – P. 1821–1830.
    • Zahorska-Markiewicz B. Serum concentration of tumor necrosis factor  at obese women / B. Zahorska-Markiewicz, J. Janowska, M. Olszanecka-Glinianowicz [et al.] // J. Endocrinol. Invest. – 1999. – № 22 (Suppl. 7). – Р. 66.
    • Zahorska-Markiewicz B. Serum concentration of TNF-α and soluble TNF-α receptors in obesity / B. Zahorska-Markiewicz, J. Janowska, M. Olszanecka-Glinianowicz [et al.] // Int. J. Obesity. – 2000. – № 24. – Р. 1392–1395.
    • Zahorska-Markiewicz B. Serum NO (nitric oxide) and TNF-α in obesity / B. Zahorska-Markiewicz, M. Olszanecka-Glinianowicz, J. Janowska [et al.] // Int. J. Obes. – 2001. – Vol. 25 (Suppl. 2). – P. 129.
    • Ziccardi P. Reduction of inflammatory cytokine concentration and improvement of endothelial function in obese women after weight loss over one year / P. Ziccardi, F. Nappo, G. Giugliano [et al.] // Circulation. – 2001. – Vol. 105. – P. 804–809.
    Publication of the article «World of Medicine and Biology» №4(42) 2 part 2013 year, 121-125 pages, index UDK 616.1 – 056.52:612.017.1:577.27